On Friday, Shares of LinkedIn Corp (NYSE:LNKD), gained 11.01% to $240.89.
EY and LinkedIn, declare a new planned alliance to jointly offer services to assist more companies around the world use technology, social networks and innovative sales techniques to empower their go-to-market efforts.
EY’s extensive business transformation knowledge, data analytic capabilities and global reach, combined with LinkedIn’s platform and network of more than 400m professionals around the globe, can effectively transform relationship administration. Together, the two organizations will assist companies develop deeper and more trusted customer relationships through the use of social and data analytics. This planned relationship will lead to partnership on the co-creation of solutions and services.
The joint offering will leverage social media as an element of building relationships with buyers. With the right tools and strategy in place, this platform has the power to build a positive reputation, unearth buried insights and establish key contacts for anyone in a revenue-generating role. In the future, there is also tremendous opportunity to drive innovation around EY’s organizational strength and LinkedIn’s platform.
LinkedIn Corporation, together with its auxiliaries, operates an online professional network worldwide. The company, through its proprietary platform, allows members to create, manage, and share their professional identity online; build and engage with their professional networks; access shared knowledge and insights; and find business opportunities.
Shares of E I Du Pont De Nemours And Co (NYSE:DD), inclined 0.14% to $63.43, during its last trading session.
DuPont celebrated the opening of its cellulosic bio fuel facility in Nevada, Iowa, with a ceremony counting Iowa Gov. Terry Brandstad and many other dignitaries. This bio refinery is the world’s largest cellulosic ethanol plant, with the capacity to produce 30 million gallons per year of clean fuel that offers a 90 percent reduction in greenhouse gas emissions as contrast to gasoline.
The raw material used to produce the ethanol is corn stover — the stalks, leaves and cobs left in a field after harvest. The facility will demonstrate at commercial scale that non-food feed stocks from agriculture can be the renewable raw material to power the future energy demands of society. Cellulosic ethanol will further diversify the transportation fuel mix just as wind and solar are expanding the renewable options for power generation.
E I. du Pont de Nemours and Company operates as a science and technology based company worldwide. The company’s Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, seed products, wheat, rice, herbicides, fungicides, and insecticides.
Finally, Shares of MiMedx Group Inc (NASDAQ:MDXG), ended its last trade with -0.14% loss, and closed at $7.28.
MiMedx Group, the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, declared recently its record results for the third quarter of 2015.
Third Quarter 2015 Highlights are:
- Q3 is 16th successive quarter of meeting or surpassing revenue guidance
- YTD 2015 revenue of $135.5 million raised by 72% over same period of 2014
- Q3 revenue of $49 million raised by 46% over Q3 2014
- Q3 revenue is at upper end of $47 to $50 million guidance range
- Q3 gross margin of 90% is up three percentage points from 87% in first quarter of 2015
- Q3 is 15th successive quarter of positive Adjusted EBITDA
- Q3 Wound Care sales grew 37% over Q3 2014
- Q3 Surgical, Sports Medicine/Orthopedic revenue raised 77% over Q3 2014
- Adjusted EBITDA of $11.8 million represents a 62% improvement over Q3 2014
- Q3 net income of $6.6 million raised 77% over Q3 2014
- Q3 EPS of $0.06 per diluted share beat consensus estimates of $0.05
MiMedx Group, Inc. develops, processes, and markets patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies are AmnioFix, EpiFix, and CollaFix.